Rep. Gus M. Bilirakis

Treat and Reduce Obesity Act of 2025 This bill expands Medicare coverage of intensive behavioral therapy for obesity. Specifically, the bill allows coverage for therapy that is provided by (1) a physician who is not a primary care physician; or (2) other health care providers (e.g., physician assistants and nurse practitioners) and approved counseling programs, if provided upon a referral from, and in coordination with, a physician or primary care practitioner. Currently, such therapy is covered only if provided by a primary care practitioner. The bill also allows coverage under Medicare's prescription drug benefit of drugs used for the treatment of obesity or for weight loss management for individuals who are overweight.

Maddy summaryThis bill makes technical corrections to the Camp Lejeune Justice Act of 2022 to streamline claims for individuals harmed by water contamination at Camp Lejeune. It clarifies the evidence required (30+ days at the base plus a link between contaminants and health harm), specifies that cases must be handled in North Carolina courts (with limited transfer options), and sets attorney fee caps (20% before suit, 25% after). These changes directly affect veterans and civilians who lived at Camp Lejeune and filed claims under the 2022 law. The bill does not create new eligibility but aims to improve the legal process for existing cases.

Maddy summaryHR 4139, the Cutting Copays Act, lowers out-of-pocket prescription drug costs for low-income Medicare Part D beneficiaries. It reduces the maximum copay for generic drugs to $0 starting in 2026 and caps copays for other drugs at $3 before 2026, with future adjustments tied to inflation. The bill directly affects Medicare Part D enrollees who qualify for low-income subsidies, ensuring their annual drug costs stay below set limits. These changes modify existing Medicare Part D cost-sharing rules without creating new programs or altering eligibility.

Maddy summaryHR 4101, the Cancer Drug Parity Act of 2025, requires group health plans and insurance plans to provide equal cost-sharing (like deductibles and copays) for oral anticancer drugs as for intravenous or injected cancer drugs. This directly affects insured cancer patients prescribed oral medications, ensuring they face no higher out-of-pocket costs than for IV treatments when medically necessary. The law prohibits plans from changing benefits to increase costs for oral drugs or applying stricter limits on them compared to IV drugs. It takes effect for plan years starting January 1, 2026, and mandates a GAO study to assess the law’s impact on patient costs within two years of enactment.

Maddy summaryThe LEDGER Act (HR 4091) requires the Treasury Department to create a system tracking every government payment within 180 days of enactment. It mandates that all federal departments, agencies, and branches (executive, legislative, judicial) must report disbursements from every funding source, including how long funds remain available for spending. This system will detail each payment's origin, recipient, and timing across all government accounts. The bill directly affects all federal spending entities by standardizing expenditure tracking previously handled inconsistently.

Maddy summaryThe Veterans Appeals Efficiency Act of 2025 requires the Department of Veterans Affairs to track and report on key aspects of the appeals process, including average claim processing times after remand and reasons for case dismissals. It mandates the creation of guidelines for advancing cases on the Board's docket and authorizes the Board to aggregate appeals with common legal or factual issues to improve efficiency. The bill also expands the Court of Appeals' jurisdiction to handle class action claims and requires a study on common legal questions to help the Board make more consistent decisions. These changes aim to reduce delays and improve the accuracy of benefits decisions for veterans seeking appeals.

Repair Abuses of MSP Payments Act or the RAMP Act This bill restricts the private right of action against insurance plans that do not provide appropriate primary payment in cases in which Medicare is a secondary payer. Current law allows for a private right of action against primary plans that do not provide appropriate primary payment in cases in which Medicare is a secondary payer; this provision applies to group health plans, workers' compensation plans, automobile or liability insurance plans, and no-fault insurance plans. The bill limits this provision to group health plans.

Maddy summaryH.J.Res. 88 disapproves an Environmental Protection Agency (EPA) rule that would have allowed California to enforce its "Advanced Clean Cars II" vehicle emission standards. This rule, submitted by the EPA on January 6, 2025, sought to grant California a waiver to override federal preemption for its stricter vehicle pollution controls. The resolution, passed by Congress and signed into law on June 12, 2025, formally nullifies the EPA rule, preventing California from implementing its Advanced Clean Cars II program under this specific waiver. The bill directly affects California's ability to set its own vehicle emission standards for passenger cars and light trucks.

Maddy summaryHJRES 89 is a congressional disapproval resolution that blocks an Environmental Protection Agency (EPA) rule concerning California's vehicle and engine pollution standards. The resolution specifically targets the EPA's "Omnibus Low NOX Regulation" and waiver of preemption, which would have allowed California to enforce stricter emissions rules. By disapproving this rule under Chapter 8 of Title 5 U.S. Code, Congress has nullified the EPA's action, meaning the regulation will have no legal effect. This directly affects the EPA's authority to approve California's state-level pollution control standards for motor vehicles.

Maddy summaryHRES 507 is a non-binding House resolution expressing support for designating June 10 as "FSGS Awareness Day." It highlights focal segmental glomerulosclerosis (FSGS), a rare kidney disease causing scarring that often leads to kidney failure, disproportionately affecting Black communities due to genetic factors. The resolution aims to raise public awareness about FSGS, support patients and families, and encourage efforts toward better diagnosis and treatments. It does not create new laws or directly affect any group.